Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptorAmarnath Mukherjee, Kumar P Narayan, Krishnendu Pal, et al.Frontiers in Oncology|September 8, 2022
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinomaKrishnendu Pal, Tabish Hussain, Hao Xie, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|March 9, 2019
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancerVijay S Madamsetty, Anil Sharma, Maria Toma, et al.Nanoscale|November 12, 2019
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancerVijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathwayMin Jae Lee, Krishnendu Pal, Takafumi Tasaki, et al.Research Square|January 10, 2024
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic CatastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 22, 2018
VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cellsRamcharan Singh Angom, Ying Wang, Enfeng Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|June 5, 2024
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastropheHari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.Oncogene|August 14, 2019
BRAFV600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenograftsDaofu Feng, Bo Qin, Krishnendu Pal, et al.Nano Letters|October 5, 2011
Reactive oxygen species driven angiogenesis by inorganic nanorodsChitta Ranjan Patra, Jong-Ho Kim, Kallal Pramanik, et al.Pageof 12